PictureRx: An Intervention to Reduce Latino Health Disparities (Supplement: Medical Icons)

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
M Brian Riley, PictureRx, LLC
ClinicalTrials.gov Identifier:
NCT01618461
First received: June 11, 2012
Last updated: NA
Last verified: June 2012
History: No changes posted
  Purpose

Research shows that well-developed icons and other pictorials aid in the comprehension of medication information and are effective in improving patients' medication management. This experimental study seeks to test the effect of icons and structured medication information on subjects' processing and recall of simulated medication instructions in a computer testing environment. The study planned to enroll 200 subjects.


Condition Intervention
Understanding of Medication Instructions
Recall of Medication Instructions
Behavioral: Drug indication icons
Behavioral: Structured instructions

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Health Services Research
Official Title: PictureRx: An Intervention to Reduce Latino Health Disparities (Supplement: Medical Icons)

Resource links provided by NLM:


Further study details as provided by PictureRx, LLC:

Primary Outcome Measures:
  • Understanding of medication instructions [ Time Frame: Within 10-20 minutes ] [ Designated as safety issue: No ]
    Participants' ability to state the drug indication


Secondary Outcome Measures:
  • Recall of medication instructions [ Time Frame: Within 10-20 minutes ] [ Designated as safety issue: No ]
    Participants' ability to recall the instructions after viewing a series of medications


Enrollment: 200
Study Start Date: June 2011
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Text instructions
Medication instructions displayed in text format
Experimental: Drug indication icons
Icons illustrate the purpose of each medication
Behavioral: Drug indication icons
Icons illustrate the purpose of each medication
Experimental: Structured instructions
Graphical format shows what time(s) of day each medication should be taken
Behavioral: Structured instructions
Graphical format shows what time(s) of day each medication should be taken
Experimental: Icons + Structured instructions
Icons illustrate the purpose of each medication, and a graphical format shows what time(s) of day each medication should be taken
Behavioral: Drug indication icons
Icons illustrate the purpose of each medication
Behavioral: Structured instructions
Graphical format shows what time(s) of day each medication should be taken

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Be at least 18 years old
  • Fluency in English or Spanish
  • Manage their own prescription medicines, and
  • Be taking at least one chronic medication

Exclusion Criteria:

  • Too ill to complete the experiment
  • Having visual acuity worse than 20/50 via Rosenbaum Visual Acuity exam (eyechart)
  • Inability to communicate in either Spanish or English
  • Overt psychiatric illnesses, overt delirium or dementia
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01618461

Locations
United States, Tennessee
Saint Thomas Family Health Center - South
Nashville, Tennessee, United States, 37211
Saint Thomas Family Health Center - West
Nashville, Tennessee, United States, 37209
Sponsors and Collaborators
PictureRx, LLC
Investigators
Principal Investigator: M Brian Riley, MA PictureRx, LLC
  More Information

No publications provided

Responsible Party: M Brian Riley, Director of Research, PictureRx, LLC
ClinicalTrials.gov Identifier: NCT01618461     History of Changes
Other Study ID Numbers: 3R43MD004048-02S1, 3R43MD004048-02S1
Study First Received: June 11, 2012
Last Updated: June 11, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by PictureRx, LLC:
Prescription drug information
Medication management

ClinicalTrials.gov processed this record on September 22, 2014